Obesity

Obesity is a worldwide problem that has tripled in the space of half a century.1 According to the World Health Organization (WHO), 39% of adults aged 18 and over are overweight and 13% are obese.
What if someone were to tell you that tucked away in our intestines, our gut microbiota could affect our appetite, our weight and our capacity for storing fat?2

The gut microbiota

What is obesity?

Obesity and overweight are most often the results of an imbalance between calories taken in and calories expended by the body – in particular, too much fat or sugar relative to actual energy expenditure.3,4 The resulting excessive increase in body fat can be harmful for health and significantly reduce life expectancy.3 Individuals who are overweight or obese are at greater risk of cardiovascular disease, as well as type 2 diabetes.5,6 Obesity is also linked to a number of cancers (such as liver and uterine cancer).6  Body mass index (BMI) provides an approximate indication of overweight and obesity. WHO considers overweight to equate to a BMI of 25 or more and obesity to a BMI of 30 or above.1

How does the microbiota fit in?

Genetic predisposition, a sedentary lifestyle, sleep deprivation, psychological factors and an unbalanced diet that includes too much fat and sugar are just some of the best known causes of obesity. Sometimes, however, adopting a wholesome lifestyle that combines exercise and a healthy diet is not enough to shed our excess weight.3 So, what's the reason?  Recent studies of intestinal flora in obese patients have revealed disruptions in the composition of their gut microbiota, creating an imbalance in the microbial ecosystem defined as (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) .7 Did you know? Rodent studies have shown that if the microbiota from an obese patient it transplanted into a mice, it gains weight as well!8 Surprised? These new insights offer hope for the discovery of new treatments. In fact, in obese individuals the microbiota is thought to be generally less abundant and less diverse,9 with fewer “good” bacteria such as Akkermansia muciniphila and bifidobacteria, and more potentially harmful bacteria.8 In such cases, the change in the balance of the microbiota is thought to allow the gut to extract energy from food more efficiently and therefore promotes energy storage in obese or overweight individuals.8 

Repercussions beyond the gut

The balance between energy taken in and energy expended lies partly in bidirectional communication between the gut and the brain - what researchers refer to as the gut-brain axis.10 This communication between neurons and bacteria is achieved through “signal” molecules which include “ (sidenote: Short chain fatty acids (SGFA) Short chain fatty acids are a source of energy (fuel) for an individual’s cells. They interact with the immune system and are implicated in communication between the gut and the brain.   Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. ) ” and “ (sidenote: Neurotransmitters Specific molecules that enable communication between the neurons (the nerve cells in the brain), as well as with the bacteria in the microbiota. They are produced by the individual’s cells and by the bacteria in the microbiota.    Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C. Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis. Int J Mol Sci. 2019;20(6):1482. ) ”.5,6,11 The gut microbiota uses these messengers to help the brain to regulate energy balance, appetite and the feeling of satiety,6 and also modulates mood and eating behaviour.9,10 It can be seen that gut microbiota and obesity are inextricably linked; when the gut microbiota is impaired, it disrupts the digestion, the body’s defence system and the brain, with which it communicates to manage hunger.9 Like in a closed electrical circuit, the different “devices”  are connected to one another and allow information (good or bad) to travel between the gut and the brain. 

Can modifying the microbiota help to lose weight?

The solution ought to be straightforward, then: slim down and melt away those extra pounds by looking after your microbiota! The experts will tell you it's not quite that simple, though: it requires an understanding of how diet, probiotics and prebiotics, and faecal microbiota transplant (FMT) influence the ecosystem of our gut microbiota. 

  • Diet: Diet is of course the number one risk factor for obesity. It is also the main driver of microbiota modulation. Currently, no categorical link has been established between the effect on intestinal flora and the extent of weight loss.12 Conversely, the response to a diet is thought to be the result of the initial composition of our intestinal microbiota.7,11
  • Probiotics: Many animal studies show that certain probiotics stand out and are thought to affect metabolic profile, weight gain or satiety in rodents.2,7,13,14 The results in humans are encouraging: while there is not so much data, certain specific probiotics had an impact on weight, BMI, waist measurement, body fat and metabolic profile.2,5,6
  • Prebiotics: The results for prebiotics differ in humans, whereas their beneficial effects have been widely demonstrated in the laboratory setting2. Generally speaking, studies show that prebiotics have an effect on satiety,7 but that there is unfortunately no knock-on effect on weight.2
  • Faecal microbiota transplant: Other therapies for modulating gut microbiota are being investigated, including faecal microbiota transplant (FMT), a current treatment for recurrent Clostridioides difficile infection. Researchers are evaluating its potential benefit in correcting dysbiosis and in influencing eating behaviour and energy metabolism.7
Sources

1  https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

2  Cerdó T, García-Santos JA, G Bermúdez M, et al. The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity. Nutrients. 2019;11(3):635.

Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298.

4  Maruvada P, Leone V, Kaplan LM, et al. The Human Microbiome and Obesity: Moving beyond Associations. Cell Host Microbe. 2017;22(5):589-599.

Barathikannan K, Chelliah R, Rubab M, et al. Gut Microbiome Modulation Based on Probiotic Application for Anti-Obesity: A Review on Efficacy and Validation. Microorganisms. 2019;7(10):456.

6  Abenavoli L, Scarpellini E, Colica C, et al. Gut Microbiota and Obesity: A Role for Probiotics. Nutrients. 2019;11(11):2690. 

Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.

Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance. Ann N Y Acad Sci. 2020;1461(1):37-52.

Mulders RJ, de Git KCG, Schéle E, et al. Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems. Obes Rev. 2018;19(4):435-451.

10 Torres-Fuentes C, Schellekens H, Dinan TG, et al. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol. 2017;2(10):747-756.

11 Rastelli M, Knauf C, Cani PD. Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders. Obesity (Silver Spring). 2018;26(5):792-800.

12 Seganfredo FB, Blume CA, Moehlecke M, et al. Weight-loss interventions and gut microbiota changes in overweight and obese patients: a systematic review. Obes Rev. 2017;18(8):832-851.

13 Lucas N, Legrand R, Deroissart C, et al. Hafnia alvei HA4597 Strain Reduces Food Intake and Body Weight Gain and Improves Body Composition, Glucose, and Lipid Metabolism in a Mouse Model of Hyperphagic Obesity. Microorganisms. 2019;8(1):35.

14 Legrand R, Lucas N, Dominique M, et al. Commensal Hafnia alvei strain reduces food intake and fat mass in obese mice-a new potential probiotic for appetite and body weight management. Int J Obes (Lond). 2020;44(5):1041-1051. 

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Stomach Cancer

Colorectal cancer and stomach cancer are two gastrointestinal cancers whose origins are most probably influenced by the intestinal microbiota.

The gut microbiota
stomach cancer

Colorectal cancer, the importance of environmental factors 

With 694,000 deaths per year around the world, colorectal cancer is the 2nd most deadly cancer. Genetic factors are a significant but minority cause of gastrointestinal cancer, which is most heavily attributed to environmental factors such as sedentary lifestyle, obesity, and, in particular unbalanced diet, which causes intestinal dysbiosis. Furthermore, the hypothesis of an imbalance between harmful and beneficial bacterial species with regard to this cancer is more than likely.

Colorectal cancer doesn’t show any symptoms for a long time, then manifests by persistent or sudden problems with intestinal transit: constipation, diarrhea, the pressing need to go, etc. 

Examining the stool for blood and colonoscopy are the two primary methods for detecting colorectal cancer.

Surgery forms the basis of treatment via the removal of part of the colon, sometimes supplemented with chemotherapy or radiation therapy. 

Bacteria responsible for 80% of stomach cancers

Although various risk factors have been identified (smoking, diet, family history, genetic predisposition), the primary cause of stomach cancer is Helicobacter pylori a pathogenic bacteria that causes chronic gastritis.

The symptoms are not very specific: stomach pain repeated nausea and vomiting, and a change in general state. Only endoscopy of the stomach and esophagus can confirm the diagnosis.

Surgery is the reference treatment for localized tumors, with partial or total removal of the stomach. For locally advanced forms, physicians also add chemotherapy.

Restoring the microbiota, therapy of the future?

Since the existence of a connection between bacteria and gastrointestinal cancers seems more than likely, manipulating the microbiota with probiotics and prebiotics is being studied as a potential therapeutic treatment.  

Sources

World Cancer Research Fund International, Colorectal cancer statistics http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/colorectal-cancer-statistics

GLOBOCAN project, Colorectal Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012 

InCA. Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. InCA, 2013. http://www.e-cancer.fr/content/download/63256/569357/file/Estimation-nationale-incidence-mortalite-par-cancer-France-1980-2012-Partie-1-V2.pdf

Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014 ; 10 : 766.

Le cancer de l'estomac : points clés. Institut national du cancer. http://www.e-cancer.fr/Patients-et-proches/Les-cancers/Cancer-de-l-estomac/Points-cles

Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, et al. Microbial Dysbiosis in Colorectal Cancer (CRC) Patients. PLOS ONE 2011 ; 6(1): e16393.

Wang LL, Yu XJ, Zhan SH, Jia SJ, et al. Participation of microbiota in the development of gastric cancer. World Journal of Gastroenterology : WJG. 2014 ; 20(17):4948-4952.

Mehta RS, Nishihara R, Cao Y, et al. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue [published correction appears in JAMA Oncol. 2019 Apr 1;5(4):579]. JAMA Oncol. 2017;3(7):921-927.

Microbiote intestinal et santé. Inserm, février 2016. http://www.inserm.fr/thematiques/physiopathologie-metabolisme-nutrition/dossiers-d-information/microbiote-intestinal-et-sante

Sobhani I, Amiot A, Le Baleur Y, et al. Microbial dysbioses and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Ther Adv Gastroenterol 2013 ; 6 : 215-29.

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Type 2 diabetes

Diabetes is a chronic disease related to dysfunction in the production or use of insulin, a hormone that regulates blood sugar. The gastrointestinal microbiota has been identified as one of the environmental factors that may be to blame.

The gut microbiota

In 2015, 415 million people had diabetes. According to WHO forecasts, it will be 642 million in 2040. Ninety percent of cases are type 2 diabetes.

Insulin resistance, the primary cause of type 2 diabetes

The primary cause of type 2 diabetes is cells in the body losing their sensitivity to insulin. This resistance to insulin makes the hormone ineffective and leads the pancreas to produce more, to the point of exhaustion. As a result, sugar accumulates in the blood, leading to hyperglycemia and serious long-term complications: myocardial infarction, stroke, arteritis in the lower limbs, kidney failure, and blindness. 

Involvement of the intestinal microbiota?

Although there is a genetic component to type 2 diabetes, lifestyle is the biggest risk factor for the disease--especially sedentism and a diet including too much fat and sugar. Certain fats and sugars set off an inflammatory response associated with metabolic disorders, which in turn increase the level of inflammation. It starts a vicious cycle, in which the gastrointestinal microbiota contributes because it is unbalanced. Researchers have shown that the gastrointestinal microbiota is disrupted in diabetics, and that this dysbiosis contributes to the disease. 

Lifestyle improvements

Above all, diabetes is treated by making lifestyle improvements: weight loss if necessary, regular physical activity, and a balanced diet. It is often necessary to add medication.
The role of certain intestinal bacteria and/or probiotics in diabetes has yet to be confirmed, but their beneficial effects (particularly on appetite and blood sugar) have opened a path for the development of new therapeutic targets for this disease, which affects millions of people.

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Antibiotic-associated diarrhea

Antibiotics are a powerful tool in the fight against bacterial infections. While treatments sometimes appear to be without obvious short-term side effects, the gut microbiota imbalance they provoke can cause diarrhea in up to 35% of patients.1-3 This antibiotic-associated diarrhea (AAD) can at times cloak serious intestinal infections.3

The gut microbiota Probiotics
Antibiotic-associated diarrhea

How do antibiotics unbalance the gut flora?

While antibiotics eradicate the (sidenote: Pathogen A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) responsible for infection, they can also destroy some of the beneficial bacteria in your microbiota, systematically causing an imbalance of varying degrees in this ecosystem. This imbalance (known as (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ) causes AAD, as the gut microbiota is less able to perform its protective functions. AAD can affect up to 35% of patients1-3 and up to 80% of children receiving antibiotic treatment.1

Image
antibiotics EN

Furthermore, while the gut microbiota shows a certain degree of resilience (i.e. it reverts to a composition similar to that existing before the antibiotic-induced imbalance), it does not always fully recover.4,5 Recent research has shown that antibiotics can alter the diversity and abundance of bacteria, and that this imbalance can be prolonged (usually 8-12 weeks after the end of treatment).1,6

Image
microbiote-antibiotique-focus1_EN

In most cases, diarrhea without further symptoms 

The main short-term consequence of antibiotic treatment is the altered bowel movements experienced by some patients, most often resulting in diarrhea. AAD is defined as three or more very loose or liquid stools within 24 hours of the beginning of antibiotic treatment or up to 2 months after its cessation.7-9 Its incidence depends on several factors, including age, context and the type of antibiotic. The diarrhea is usually mild to moderate in intensity and in the vast majority of cases is functional, i.e. associated with a gut microbiota imbalance.1 Antibiotics with the broadest spectrum of antimicrobial activity (i.e. that act on a very wide range of bacteria) are associated with higher rates of diarrhea.3

Antibiotics save life! Did you know that they also have an impact on your microbiota? Did you know that the misuse and overuse of antibiotics can lead to antibiotic resistance? Have you heard about the World AMR Awareness Week (WAAW)? All the answers in this dedicated page:

Antibiotics: what impact on the microbiota and on our health?

Learn more

However, in 10%-20% of cases the diarrhea results from an infection by Clostridioides difficile (C. difficile), a bacterium that can become pathogenic due to certain factors, such as antibiotic use, being older than 65 or being affected by certain associated conditions.3 The colonization of the gut microbiota by this bacterium triggers an inflammatory reaction, with clinical consequences ranging from moderate diarrhea to much more serious symptoms, including death.3

Is ending antibiotic use the most effective treatment?

The management of AAD depends on the symptoms and the pathogen (e.g. C. difficile).10 For mild to moderate diarrhea, treatment involves ending antibiotic use (or replacing the antibiotic with one less likely to cause diarrhea) to allow the microbiota to recover and the patient to rehydrate.10

Numerous studies have shown that probiotics may help reconstitute the gut microbiota, while some probiotics have proven effective in preventing and treating AAD.6,11,12 When taken during antibiotic treatment, other probiotics have been shown to reduce the risk of primary and secondary infection with C. difficile.13-15 Lastly, fecal microbiota transplantation (naturally transferring a healthy microbiota into a sick individual in order to restore his or her microbial ecosystem) is currently only used for the most serious infections, i.e. relapses of infections with C. difficile.16,17

This article is based on scientifically approved sources but is not a substitute for medical advice. If you or your child display symptoms, please consult your family doctor or pediatrician.

What is the World AMR Awareness Week?

Each year, since 2015, the WHO organizes the World AMR Awareness Week (WAAW), which aims to increase awareness of global antimicrobial resistance. 

Antimicrobial resistance occurs when bacteria, viruses, parasites and fungi change over time and no longer respond to medicines. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become increasingly difficult or impossible to treat, increasing the risk of disease spread, severe illness and death.


Held on 18-24 November, this campaign encourages the general public, healthcare professionals and decision-makers to use antibiotics, antivirals, antifungals and antiparasitics carefully, to prevent the further emergence of antimicrobial resistance. 

Sources

1 McFarland LV, Ozen M, Dinleyici EC et al. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol. 2016;22(11):3078-3104.

2  Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334-9.

3  Theriot CM, Young VB. Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol. 2015;69:445-461.

4 Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108 Suppl 1(Suppl 1):4554-4561.

5  Francino MP. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front Microbiol. 2016;6:1543.

6 Kabbani TA, Pallav K, Dowd SE et al. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes. 2017;8(1):17-32.

7 Wiström J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001 Jan;47(1):43-50. 

8 McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis. 1998 Sep-Oct;16(5):292-307. 

9 Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531-4. 

10 Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ. 2002 Jun 8;324(7350):1345-6. 

11 Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015 Oct;42(7):793-801. 

12 Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012 May 9;307(18):1959-69. 

13 McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994 Jun 22-29;271(24):1913-8. 

14 Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005 Mar 1;21(5):583-90. 

15 McFarland LV. Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review. Antibiotics (Basel). 2015 Apr 13;4(2):160-78. 

16 Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013 Apr;108(4):478-98; quiz 499.

17 Li YT, Cai HF, Wang ZH, et al. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther. 2016 Feb;43(4):445-57.

 

BMI-21.28
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease Off

Infantile colic

“My newborn baby’s cry is the most heartbreaking sound I’ve ever heard”.1 So confess many parents who turn up helpless at their pediatrician’s office, unable to soothe their baby’s inexplicable cries. The symptoms are often difficult to identify and can be an ordeal for parents, and so it’s important to know how to recognize and understand them. Does the answer lie in your baby’s gut microbiota?

The gut microbiota
Infantile colic

What is infantile colic?

Infantile colic is characterized by excessive crying for unknown reasons in otherwise healthy infants. Gastrointestinal disorders (e.g. immaturity of the gastrointestinal tract, an allergy or intolerance to cow’s milk, stomach reflux)2 are mainly to blame,3 but other causes unrelated to the gastrointestinal system,3 such as parental stress,4 or maternal smoking, have also been studied.2

Colic is common in babies, but its symptoms, such as persistent crying, can cause distress in parents.

 

Did you know? 

The word “colic” comes from the Greek “κoλικóς” (kolikos), in reference to the colon. However, despite years of research, the cause of infantile colic remains unknown and it is not entirely certain that the intestines (and therefore the colon) are involved.5

What are the symptoms of infantile colic?

The baby cries a lot, is inconsolable, grimaces and may have a red face. It keeps its fists clenched and may have gas.5 Pediatricians have long used the “rule of three” to diagnose infantile colic.6 Introduced in 1954, these criteria have since been adapted by an international organization to give a new definition with the following criteria: recurrent and prolonged periods of restlessness, crying or irritability without obvious cause such as stunted growth, fever or ill health, and which cannot be prevented or resolved by the caregivers.7

What is the gut microbiota’s role?

A link between infantile colic and the gut microbiota – also known as the gut flora – has recently been established.8 Studies have shown that the gut microbiota of infants affected by colic differs from that of other babies:9


This gut microbiota imbalance, known as a “ (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ”, appears to be strongly linked to colic: according to one hypothesis, an altered gut microbiota composition modifies intestinal motility (the way in which food moves through the digestive system), resulting in excessive production of gas.5

Gut inflammation: follow the calprotectin

The protein calprotectin can be used to identify gut inflammation. It is found in large quantities in infants suffering from colic and is associated with reduced gut microbiota diversity.9

How to help babies... and parents?

The family doctor is still the first port of call to diagnose infant colic and reassure parents. There is no cure10 for colic, but a few simple daily practices can help relieve the symptoms. These include breastfeeding, carrying your baby and balancing your child’s gut microbiota, particularly using probiotics.5 Probiotics appear to be a promising avenue, since the intake of “good” bacteria for a few months may reduce gut inflammation6 and help shorten the daily duration of crying.11 Since they help maintain a good intestinal balance, probiotics can also be used as a preventative measure.5

This article is based on scientifically approved sources but is not a substitute for medical advice. If your child displays symptoms, please consult your family doctor or pediatrician.

Sources

1 Groopman J. The Colic Conundrum. The crying that doctors can’t stop. Annals of Medicine, Sept 17, 2007 Issue. https://www.newyorker.com/magazine/2007/09/17/the-colic-conundrum

2 konieczna-Żydecka K, Janda K, Kaczmarczyk M, et al. The Effect of Probiotics on Symptoms, Gut Microbiota and Inflammatory Markers in Infantile Colic: A Systematic Review, Meta-Analysis and Meta-Regression of Randomized Controlled Trials. J Clin Med. 2020 Apr 2;9(4):999.

3 Gupta SK. Is colic a gastrointestinal disorder? Curr Opin Pediatr. 2002 Oct;14(5):588-92. 

4 van den Berg MP, van der Ende J, Crijnen AA, et al. Paternal depressive symptoms during pregnancy are related to excessive infant crying. Pediatrics. 2009 Jul;124(1):e96-103. 

Indrio F, Dargenio VN, Giordano P, et al. Preventing and Treating Colic. Adv Exp Med Biol. 2019;1125:49–56.

WESSEL MA, COBB JC, JACKSON EB, et al. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics. 1954 Nov;14(5):421-35. 

Zeevenhooven J, Koppen IJ, Benninga MA. The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers. Pediatr Gastroenterol Hepatol Nutr. 2017 Mar;20(1):1-13. 

8 Verduci E, Arrizza C, Riva E, et al. Microbiota and infantile colic: what’s new? Int J Probiotics Prebiotics. 2013; 8(1):25–28

Rhoads JM, Collins J, Fatheree NY, et al. Infant Colic Represents Gut Inflammation and Dysbiosis. J Pediatr. 2018 Dec;203:55-61.e3. 

10 Daelemans S, Peeters L, Hauser B, et al. Recent advances in understanding and managing infantile colic. F1000Res. 2018 Sep 7;7:F1000 Faculty Rev-1426. 

11 Sung V, D'Amico F, Cabana MD, et alLactobacillus reuteri to Treat Infant Colic: A Meta-analysis. Pediatrics. 2018 Jan;141(1):e20171811. 

12 O'Callaghan A, van Sinderen D. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol. 2016 Jun 15;7:925.

13 Ruiz L, Delgado S, Ruas-Madiedo P, et al. Bifidobacteria and Their Molecular Communication with the Immune System. Front Microbiol. 2017 Dec 4;8:2345.

14 W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel 

15 Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004 Jun;70(6):3189-94.

16 Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007.

BMI-21.18

 

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Vaginal yeast infection

Is the microbiota involved in vaginal yeast infections?

70%-75% of women suffer from a vaginal yeast infection (vaginal candidiasis) at least once in their life.1 Symptoms of the disease, such as itching and abnormal vaginal discharge, can be particularly troublesome in everyday life. Do vaginal microbiota imbalances facilitate infection?2

The vaginal microbiota
Vaginal microbiota

What is a vaginal yeast infection?

A vaginal yeast infection is an infection of the vulva and the vagina caused by a yeast-like fungus, in most cases Candida albicans3. After bacterial vaginosis, it is the second most common infectious vaginal disease.1 It is important to consult a doctor to confirm diagnosis, since its symptoms are not very specific. The most common clinical symptoms are abnormal vaginal discharge (leukorrhea), genital itching, and a burning sensation accompanied by vaginal pain or irritation that can lead to (sidenote: Dyspareunia Recurrent or persistent genital pain during sexual intercourse. ) or (sidenote: Dysuria Painful urination, often described by the patient as a burning, tingling or itching sensation. ) .1

42% Fewer than 1 in 2 women say that their doctor has ever explained to them how to maintain a balanced vaginal microbiota or educated on the importance of preserving as much as possible the balance of their vaginal microbiota

Is the vaginal microbiota involved?

Every woman’s vaginal microbiota is unique and, unlike other microbiota, the vaginal microbiota is well-balanced when its diversity is low4 Species of the genus (sidenote: Lactobacilli Rod-shaped bacteria whose main characteristic is the production of lactic acid, from where they get the name “lactic acid bacteria”.  Lactobacilli are present in the oral, vaginal and gut microbiota of humans, but also in plants and animals. They are found in fermented foods, such as dairy products (e.g. certain cheeses and yoghurts), pickles, sauerkraut, etc. Lactobacilli are also found in probiotics, with certain species recognized for their beneficial properties.   W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria, 2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004 Jun;70(6):3189-94. Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007. ) dominate the vaginal microbiota,4 but yeasts such as Candida albicans are also found in smaller quantities.5

The vaginal ecosystem evolves over the course of a woman’s life.6 This change is normal and is influenced by the menstrual cycle, puberty and the menopause, sexual activity, contraception, intimate hygiene, and pregnancy.7,8,9

A (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) is when the vaginal ecosystem is unbalanced (due to antibiotic treatment, douching, stress, smoking, etc.)2,6: species of Lactobacillus no longer predominate and instead certain (sidenote: Opportunistic infection An infection caused by a microorganism that is normally non-pathogenic, but which becomes so when the host microbiota loses its balance (through factors such as a weakened immune system, disease, age, certain medication, etc.). ) species may proliferate. This is what happens with vaginal candidiasis: Candida – yeasts normally present in the vagina and the gut5 – proliferate abnormally and become pathogenic under specific conditions. It is estimated that 10%-30% of women contract yeast infections following antibiotic treatment.10

10%-30% of women contract yeast infections following antibiotic treatment

Other factors that can increase the risk of infection1 include corticosteroid use, pregnancy, immunosuppressive diseases, poorly controlled diabetes, oral contraception, and IUD. Many factors have been identified but the mechanisms are not yet fully understood.11

Antifungals and probiotics

The classic treatment for vaginal yeast infections is antifungal medication administered orally or topically.11 However, relapses can occur and new therapeutic approaches are currently being evaluated.11 Recent work suggests that oral or topical probiotics (capsules or vaginal suppositories) may rebalance the vaginal microbiota and reduce the frequency of relapse.12,13

To reduce the risk of infection, certain intimate hygiene practices are recommended14 – daily habits to help care for your vaginal microbiota.  

This article is based on scientifically approved sources. If you experience symptoms, please consult your family doctor or gynecologist.

Sources

1 Gonçalves B, Ferreira C, Alves CT, et al. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016 Nov;42(6):905-27. 

2 Riepl M. Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome. Int J Pharm Compd. 2018 Nov-Dec;22(6):456-465.

3 Ceccarani C, Foschi C, Parolin C, et al. Diversity of vaginal microbiome and metabolome during genital infections. Sci Rep. 2019 Oct 1;9(1):14095.

4 Gupta S, Kakkar V, Bhushan I. et al. Crosstalk between Vaginal Microbiome and Female Health: A review. Microb Pathog. 2019 Aug 23;136:103696.

5 d'Enfert C, Kaune AK, Alaban LR, et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev. 2020 Nov 24:fuaa060. 

6 Amabebe E, Anumba DOC. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Front Med (Lausanne). 2018 Jun 13;5:181.

7 Gupta P, Singh MP, Goyal K. Diversity of Vaginal Microbiome in Pregnancy: Deciphering the Obscurity. Front Public Health. 2020 Jul 24;8:326.

8 Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019 Apr;220(4):324-335.

9 Lewis FM, Bernstein KT, Aral SO. Vaginal Microbiome and Its Relationship to Behavior, Sexual Health, and Sexually Transmitted Diseases. Obstet Gynecol. 2017;129(4):643-654.

10  Shukla A, Sobel JD. Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure. Curr Infect Dis Rep. 2019 Nov 9;21(11):44.

11 de Cássia Orlandi Sardi, J, Silva, D.R, et al. Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options. Curr Fungal Infect Rep 15, 32–40 (2021). 

12 Strus M, Chmielarczyk A, Kochan P, et al. Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal flora. Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):210-5. 

13 Vujic G, Jajac Knez A, Despot Stefanovic V, et al. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2013 May;168(1):75-9. 

14 Chen Y, Bruning E, Rubino J, et al. Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage. Womens Health (Lond). 2017 Dec;13(3):58-67.

15 Hill DA, Taylor CA. Dyspareunia in Women. Am Fam Physician. 2021 May 15;103(10):597-604.

16 Wrenn K. Dysuria, Frequency, and Urgency. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 181. 

17 Brown SP, Cornforth DM, Mideo N. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends Microbiol. 2012 Jul;20(7):336-42.

18 W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria, 2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel 

BMI-21.21
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Bacterial vaginosis - vaginal microbiota imbalance

The most common gynecological disorder in women of childbearing age, bacterial vaginosis affects 23%-29% of women worldwide.1 The disorder is hit and miss: it can go completely unnoticed or significantly alter a woman’s life. The cause remains unknown, but a vaginal microbiota imbalance seems the most likely explanation.2

The vaginal microbiota
Is bacterial vaginosis a disease?

What is bacterial vaginosis?

Bacterial vaginosis is a harmful and hard to detect disorder. 50% of women are asymptomatic, while others suffer from local irritation or foul-smelling discharge.3

In practice, doctors use the Amsel score4 to diagnose bacterial vaginosis. Diagnosis is based on the presence of at least three of the following criteria:

  • Thin, homogeneous vaginal discharge 
  • A vaginal pH above 4.5 
  • An amine smell (similar to a fishy smell) after a specific test is performed on a vaginal smear
  • Presence of vaginal tissue cells coated with bacteria when discharge is examined microscopically

Many risk factors are associated with the disease, including age, menstrual cycle, pregnancy, and sexual history, but also vaginal douching and smoking.3 A vaginal dysbiosis induced by antibiotic treatment may also participate in the development of bacterial vaginosis, creating a vicious circle, since antibiotics can be used to treat the infection.3

Lastly, women with bacterial vaginosis are more likely to contract sexually transmitted infections (STIs), including herpes, HPV, AIDS and bacterial infections.5,6

50% of women are asymptomatic, while others suffer from local irritation or foul-smelling discharge

Is there a link with the vaginal microbiota?

Bacterial vaginosis is associated with an imbalance ( (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) ) of the vaginal microbiota.2 The vaginal microbiota is dominated by different species of the bacterial genus (sidenote: Lactobacilli Rod-shaped bacteria whose main characteristic is the production of lactic acid, from where they get the name “lactic acid bacteria”.  Lactobacilli are present in the oral, vaginal and gut microbiota of humans, but also in plants and animals. They are found in fermented foods, such as dairy products (e.g. certain cheeses and yoghurts), pickles, sauerkraut, etc. Lactobacilli are also found in probiotics, with certain species recognized for their beneficial properties.   W. H. Holzapfel et B. J. Wood, The Genera of Lactic Acid Bacteria, 2, Springer-Verlag, 1st ed. 1995 (2012), 411 p. « The genus Lactobacillus par W. P. Hammes, R. F. Vogel Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004 Jun;70(6):3189-94. Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr. 2013 Jun;109(11):1999-2007. ) . These bacteria help maintain an acidic pH in the vagina and thus prevent the proliferation of pathogenic bacteria.7 The vaginal microbiota also contains yeasts such as Candida albicans in smaller quantities.8


With bacterial vaginosis, this normal microbial flora is replaced by a polymicrobial flora comprising numerous bacteria (Gardnerella, Atopobium, Prevotella, Mobiluncus, etc.).2 This leads to an increase in the pH of the vagina (which is normally very acidic), mainly attributed to the decrease in the predominance of Lactobacillus species.9 However, the mere presence of species from this polymicrobial flora does not in itself seem to cause infection, i.e. a woman whose vagina contains Atopobium or Prevotella species will not necessarily report symptoms. In fact, Gardnerella vaginalis is present in 90% of symptomatic subjects and 45% of healthy subjects.4 For a long time, this bacterium was considered the main pathogen behind bacterial vaginosis, but new research has shown that Gardnerella vaginalis can colonize the vagina without triggering infection.10 The causes of the infection are yet to be determined and research in the area continues.3

35% Only 1 in 3 women know that bacterial vaginosis is associated with an imbalance in the vaginal microbiota

69% Almost 7 out of 10 women are aware that antibiotics can alter the vaginal microbiota.

How to avoid bacterial vaginosis

Treatment is only recommended for women who are symptomatic. Recommended treatment currently involves the prescription of oral or vaginal antibiotics.2 While antibiotics may help alleviate symptoms, relapse is unfortunately very common.11

However, there are a number of ways to reduce your chances of getting bacterial vaginosis. Firstly, avoid certain risk factors, such as vaginal douching or smoking.3 Vaginal or oral probiotics,12,13 that restore the balance of the vaginal microbiota can be used to treat or prevent relapses.

This article is based on scientifically approved sources. If you experience symptoms, please consult your family doctor or gynecologist.

Sources

1  Peebles K, Velloza J, Balkus JE, et al. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2019 May;46(5):304-311. 

2 Chen X, Lu Y, Chen T, et al. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021 Apr 7;11:631972. 

3 Coudray MS, Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2019 Dec 24;245:143-148

4 Onderdonk AB, Delaney ML, Fichorova RN. The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev. 2016 Apr;29(2):223-38. 

5 Lewis FM, Bernstein KT, Aral SO. Vaginal Microbiome and Its Relationship to Behavior, Sexual Health, and Sexually Transmitted Diseases. Obstet Gynecol. 2017;129(4):643-654.

6 Torcia MG. Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections. Int J Mol Sci. 2019;20(2):266.

7 Greenbaum S, Greenbaum G, Moran-Gilad J, et al. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019 Apr;220(4):324-335.

8 d'Enfert C, Kaune AK, Alaban LR, et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev. 2020 Nov 24:fuaa060. 

9 Aldunate M, Srbinovski D, Hearps AC, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015 Jun 2;6:164. 

10 Muzny CA, Taylor CM, Swords WE, et al. An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis. J Infect Dis. 2019 Sep 26;220(9):1399-1405. 

11 Bradshaw CS, Brotman RM. Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure. BMC Infect Dis. 2015 Jul 29;15:292. 

12 López-Moreno A, Aguilera M. Vaginal Probiotics for Reproductive Health and Related Dysbiosis: Systematic Review and Meta-Analysis. J Clin Med. 2021 Apr 2;10(7):1461. 

13 Koirala R, Gargari G, Arioli S, et al. Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study. FEMS Microbiol Ecol. 2020 Jun 1;96(6):fiaa084. 

BMI-21.22
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

Travelers’ diarrhea

It's not what you think...

Notice to globetrotters and travelers who’ve fallen victim to the dreaded “tourista”: this mostly benign infection which disrupts the gut microbiota1 is actually called travelers’ diarrhea. A very common disease, it occurs in 10% to 40% of tourists2 on a two-week trip, depending on the country visited and the characteristics of the traveler. It affects up to 60% of travelers in tropical or subtropical regions.Although different in many ways from gastroenteritis, both diseases cause diarrhea.2

The gut microbiota Antibiotic-associated diarrhea
Travelers’ diarrhea

What is travelers’ diarrhea?

Contrary to popular belief, travelers’ diarrhea is not caused by exotic foods poorly digested by unaccustomed stomachs. It is a real infection most frequently caused by bacteria  (Escherichia coli, Salmonella, Shigella, Campylobacter).2 It may also be caused by a parasite (Giardia, Cryptosporidium, etc.)2 or a virus (norovirus, rotavirus).2 The pathogen responsible for the diarrhea is identified in only 40%-60% of symptomatic travelers.4 The main source of the microorganisms involved are contaminated food (especially raw vegetables, undercooked meat or fish, unpeeled fruit, etc.) and contaminated water.5 It can also be transmitted through contact with other people when hygiene rules are not respected.5

40%-60% The pathogen responsible for the diarrhea is identified in only 40%-60% of symptomatic travelers

What is the microbiota’s role? 

One of the gut microbiota’s roles is to prevent or limit the invasion of the intestine by (sidenote: Pathogens A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) .6 Although common, the “tourista” is not without consequences. Regardless of the pathogen, diarrhea disrupts the balance of the gut microbiota at least temporarily, leading to (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) .1 This imbalance may have long-term consequences, including an increased risk of developing post-infectious7 irritable bowel syndrome, which occurs in 3%-17% of patients.2 A research team recently showed that gut microbiota diversity was significantly lower in Swedish travelers who contracted a Campylobacter infection than in travelers who remained uninfected.8 Another research team found that diarrhea during travel was associated with a higher relative abundance in the gut of a specific bacteria (Prevotella copri) before departure and after return.9 Could travelers’ gut microbiota composition be used to predict the risk of developing diarrhea during the trip? Since there are still very few studies in this area, it remains to be confirmed.

What are the symptoms of traveler’s diarrhea?

The symptoms and duration vary depending on the cause4 (bacterial, parasitic or viral), but on average symptoms last 4-5 days without treatment.2 In addition to frequent loose or watery stools (at least 3 per day),5 at least one of the following symptoms must be present: fever, nausea, vomiting, abdominal cramps or an urgent need to go to the bathroom.2 The major risk is dehydration resulting from the loss of fluids through watery diarrhea. At-risk individuals (children, the elderly, or those with chronic conditions that weaken the immune system2) are more likely to be hospitalized.

Definition of travelers' diarrhea:

Mild

Tolerable diarrhea that does not interfere with planned activities.

Moderate

Diarrhea that restricts or interferes with planned activities.

Severe

Disabling diarrhea that results in complete inability to perform planned activities. Dysentery, i.e. diarrhea accompanied by blood and/or mucus, is considered a type of severe diarrhea.

Persistent

Diarrhea that lasts more than two weeks.

How to prevent and treat travelers’ diarrhea

The prevention of travelers’ diarrhea mainly involves hygiene measures such as frequent hand washing and food precautions.5 Ask your doctor or pharmacist for advice before traveling. Rehydration is key to treating travelers’ diarrhea:5 clean water (bottled water, etc.) or herbal teas drunk often and in small quantities. Any lightly sweetened and/or salted food is recommended (solid foods are not contraindicated).4 Antidiarrheal drugs help reduce the risk of dehydration and may be recommended in some cases.10 Antibiotics may also be necessary. However, antibiotics can lead to a reduction in the diversity of the gut microbiota, which thus loses its ability to act as a barrier against (sidenote: Pathogen A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) . Moreover, antibiotic use can lead to the selection of antibiotic-resistant bacteria.11 For this reason, they are only recommended for severe diarrhea, and in some cases for moderate diarrhea,10 under the supervision of a doctor. Probiotics may be useful as a preventive measure12, and to limit the intensity and duration of symptoms.13,14

This article is based on scientifically approved sources but is not a substitute for medical advice. If you experience symptoms, please consult your family doctor.

Sources

Youmans BP, Ajami NJ, Jiang ZD et al. Characterization of the human gut microbiome during travelers’ diarrhea. Gut Microbes. 2015;6(2):110-9. 

Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. JAMA. 2015 Jan 6;313(1):71-80. 

Eckbo EJ, Yansouni CP, Pernica JM, et al. New Tools to Test Stool: Managing Travelers' Diarrhea in the Era of Molecular Diagnostics. Infect Dis Clin North Am. 2019 Mar;33(1):197-212.

Fedor A, Bojanowski I, Korzeniewski K. Gastrointestinal infections in returned travelers. Int Marit Health. 2019;70(4):244-251. 

World Health Organization. 2017. Diarrhoeal disease. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs330/en/. Accessed 28 October 2017.

Riddle MS, Connor BA. The Traveling Microbiome. Curr Infect Dis Rep. 2016 Sep;18(9):29.

Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol. 2014 Apr 14;20(14):3976-85. 

Kampmann C, Dicksved J, Engstrand L, et al. Composition of human faecal microbiota in resistance to Campylobacter infection. Clin Microbiol Infect. 2016 Jan;22(1):61.e1-61.e8.

Leo S, Lazarevic V, Gaïa N, et al. The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions. Gut Microbes. 2019;10(5):631-641.

10 Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med. 2017 Apr 1;24(suppl_1):S57-S74.

11 McDonald LC. Effects of short- and long-course antibiotics on the lower intestinal microbiome as they relate to traveller's diarrhea. J Travel Med. 2017 Apr 1;24(suppl_1):S35-S38.

12 McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010 May 14;16(18):2202-22. 

13 Dinleyici EC, Eren M, Ozen M, et al. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther. 2012 Apr;12(4):395-410.

14 Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003048. 

15 Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. 

BMI 21.20
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Disease

The skin microbiota

The skin microbiota: why is it so important?

skin microbiota

35% only 1 in 3 people knew that it was better not to wash twice a day to preserve their skin’s microbiota

What exactly is the skin microbiota?

Let’s start by focusing on the skin, the largest organ in the human body and its first line of defense. The skin acts as a triple protective barrier:1,2

  • a physical barrier that protects the internal organs from the external environment3
  • a chemical barrier: dry and rich in salt and acidic compounds, the skin is a hostile environment for many microorganisms4
  • an immune barrier, thanks to defense cells in the skin that prevent colonization and infection by pathogenic microbes2

Despite this, the skin is home to its own distinctive microbiota which includes bacteria (Cutibacterium acnes, Staphylococcus epidermidis, etc.), fungi (e.g. Malassezia), viruses (e.g. papillomavirus) and parasites (including mites such as Demodex). These microorganisms live in perfect harmony and together form the skin microbiota.1,5

As you may have noticed, your skin changes from one part of the body to another: 

  • drier on the forearm and the palms of the hand.1,5
  • oilier on the face, chest and back.1,5
  • and more humid in the armpits, the elbow fold, the nostrils, on the back of the knee and on the groin.1,5

Each of these skin sites is home to a distinct microbiota adapted to its specific environment1. Some researchers also distinguish a fourth site in the foot (nails, heel and space between toes).1
In addition to these variations across the skin’s surface, there are also variations according to depth or skin layer: the deeper you go into the dermis, the fewer the (sidenote: Microorganisms Living organisms too small to see with the naked eye. This includes bacteria, viruses, fungi, archaea, protozoa, etc., collectively known as ’microbes’. Source: What is microbiology? Microbiology Society. ) and the more similar these microorganisms are from one person to next.6

How does the skin microbiota change throughout life?

The skin microbiota is relatively stable over time1,5 and only changes at the major stages of life. 

At birth, children born vaginally are passed on vaginal bacteria (Lactobacillus, C. albicans), while those born by caesarean section receive skin microbes (Staphylococcus, Streptococcus). At puberty, the rate of secretion of growth hormones explodes. The skin becomes oilier and selects more well-adapted microorganisms that live on through adulthood. The skin gradually changes as it ages, with a weakened immune system, reduced cell renewal, less sweat, and altered sebum production.7,8

These physiological changes modify the skin environment and alter the microbial balance7, which becomes more diverse and sees a change in dominance in bacterial groups.8

Why is the skin microbiota a key factor in skin health?

The skin microbiota knows how to thank its host for giving it food and shelter. It protects the host from (sidenote: Pathogens A pathogen is a microorganism that causes, or may cause, disease. Pirofski LA, Casadevall A. Q and A: What is a pathogen? A question that begs the point. BMC Biol. 2012 Jan 31;10:6. ) through its physical presence on the skin and by secreting antibacterial molecules and acids.2 But that’s not all. The skin microbiota also plays a key role in immunity: it stimulates the immune defense mechanisms of the epidermis and the body as a whole and calms inflammation where necessary.4

What diseases are associated with an unbalanced skin microbiota?

The composition of the skin microbiota is mostly influenced by host characteristics (age, sex, genes, immune status, diet, stress levels) and the environment (lifestyle, domestic and personal hygiene, living arrangements, geographical location, sun exposure, etc.).2 At times, factors such as stress, a lifestyle change or the use of medication (e.g. antibiotics) or personal hygiene products disrupt the balance of the microbiota: bacteria previously beneficial to the host take the upper hand and become pathogenic.1 Many common skin diseases are associated with changes in the microbiota. This situation is known as a (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) .1

Dysbiosis is often associated with pathological skin conditions such as acne,9 atopic dermatitis,10 psoriasis,11 seborrheic dermatitis,12 rosacea13 or skin cancer.14 Changes in the skin microbiota can also be observed in non-pathological skin conditions such as sensitive skin, sensations of discomfort or irritation, or diaper rash. The skin is constantly exposed to various external factors linked to lifestyle (cold, heat, sun, UV, hygiene products, etc.) or the individual (genes, sensitivity, allergies, etc.) that can affect the physical, mechanical or microbial properties of the skin barrier.15 The microbiota is also involved in wound healing16 and body odor.17

The gut-skin axis

The gut and the skin are intimately linked. The communication channel between them is known as gut-skin axis. Several common skin diseases, such as acne, atopic dermatitis, psoriasis and rosacea have been associated with gut dysbiosis.18

How can you take care of your skin microbiota? 

You now know the importance of the skin microbiota for the health of your skin, and that the gut microbiota also plays a role in skin health. So how can you take care of the various microbiota so that your skin stays healthy? Many researchers have looked into this question. Unfortunately, the answer isn’t as straightforward as using beneficial bacteria or yeast to replenish or enrich the existing microbiota or replace a microbiota that’s not up to the job. Instead, the idea is to modify the microbiota so that it functions correctly, thus improving host health. How? There are several ways to improve the balance and diversity of the gut microbiota, each with its own characteristics:

Oral preparation: 

The existence of a gut-skin axis raises hope that we may be able improve the health of the skin by modulating the gut microbiota by taking probiotic, prebiotic and symbiotic supplement or through a better diet:

  • Probiotics are living microorganisms that confer a health benefit on the host when applied in appropriate quantities19,20. For certain inflammatory skin diseases, the use of specific probiotics appears to be effective.14
  • Prebiotics are specific non-digestible dietary fibers that confer a health benefit. They are selectively used by beneficial microorganisms in the host microbiota.21,22 Symbiotics23 mixture containing both prebiotic and probiotic have shown promising results in atopic dermatitis.24
  • Diet, the diversity and quality of what we eat contributes to the balance of our gut microbiota.25,26 A poorly balanced diet can affect the composition of the gut and give rise to certain conditions.27 To keep our gut in shape we should know what foods have a beneficial or adverse effect on it.28

Topical preparations

While few studies existed, products applied to the skin that contain certain probiotics, prebiotics or both, have shown positive resulted in improving the skin's health of patient with skin condition.14,24

However, clinical trials are still required to optimize their formulation. Hence the importance of following our latest news on the skin microbiota.

All the information in this article comes from scientific approved sources. Keep in mind this is not exhaustive. Here are all the studies from which we took all of that information.

Sources

Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143-155.

Egert M, Simmering R, Riedel CU. The Association of the Skin Microbiota With Health, Immunity, and Disease. Clin Pharmacol Ther. 2017 Jul;102(1):62-69.

Ederveen THA, Smits JPH, Boekhorst J et al. Skin microbiota in health and disease: From sequencing to biology. J Dermatol. 2020 Oct;47(10):1110-1118.

Flowers L, Grice EA. The Skin Microbiota: Balancing Risk and Reward. Cell Host Microbe. 2020;28(2):190-200.

Barnard E, Li H. Shaping of cutaneous function by encounters with commensals. J Physiol. 2017 Jan 15;595(2):437-450.

Bay L, Barnes CJ, Fritz BG et al. Universal Dermal Microbiome in Human Skin. mBio. 2020 Feb 11;11(1):e02945-19.

Bonté F, Girard D, Archambault JC, Desmoulière A. Skin Changes During Ageing. Subcell Biochem. 2019;91:249-280.

Shibagaki, N., Suda, W., Clavaud, C. et al. Aging-related changes in the diversity of women’s skin microbiomes associated with oral bacteria. Sci Rep 7, 10567 (2017).

Dreno B, Dagnelie MA, Khammari A, et al. The Skin Microbiome: A New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):18-24.

10 Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020 Aug 1;396(10247):345-360.

11 Rigon RB, de Freitas ACP, Bicas JL, et al. Skin microbiota as a therapeutic target for psoriasis treatment: Trends and perspectives. J Cosmet Dermatol. 2021;20(4):1066-1072.

12 Adalsteinsson JA, Kaushik S, Muzumdar S et al. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29(5):481-489

13 Tutka K, Żychowska M, Reich A. Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea-A Systematic Review of the Literature. Microorganisms. 2020;8(11):1756.

14 Yu Y, Dunaway S, Champer J, et al.Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2020;182(1):39-46.

15 Seite S, Misery L. Skin sensitivity and skin microbiota: Is there a link? Exp Dermatol. 2018 Sep;27(9):1061-1064.

16 Johnson TR, Gomez BI, McIntyre MK, et al. The Cutaneous Microbiome and Wounds: New Molecular Targets to Promote Wound Healing. Int J Mol Sci. 2018;19(9):2699.

17 Schneider AM, Nelson AM. Skin microbiota: Friend or foe in pediatric skin health and skin disease. Pediatr Dermatol. 2019 Nov;36(6):815-822.

18 Szántó M, Dózsa A, Antal D, et al. Targeting the gut-skin axis-Probiotics as new tools for skin disorder management? Exp Dermatol. 2019 Nov;28(11):1210-1218.

19 FAO/OMS, Joint Food and Agriculture Organization of the United Nations/ World Health Organization. Working Group. Report on drafting  guidelines for the evaluation of probiotics in food, 2002.

20 Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506–514 (2014).

21 Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics .J Nutr, 1995; 125:1401-12.

22 Gibson G, Hutkins R, Sanders M, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14, 491–502 (2017).

23  Markowiak P, Śliżewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9):1021. Published 2017 Sep 15.

24 Bustamante M, Oomah BD, Oliveira WP, et al. Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract. Folia Microbiol (Praha). 2020;65(2):245-264.

25 Tap J, Furet JP, Bensaada M, et al. Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults. Environ Microbiol. 2015 Dec;17(12):4954-64. 

26 Quigley EMM, Gajula P. Recent advances in modulating the microbiome. F1000Res. 2020 Jan 27;9:F1000 Faculty Rev-46.

27 Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56.

28 Wilson AS, Koller KR, Ramaboli MC, et al. Diet and the Human Gut Microbiome: An International Review. Dig Dis Sci. 2020;65(3):723-740.

BMI-21.13
 
Summary
On
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Microbiota

The ENT microbiota

The ENT (ear, nose, throat) microbiota is made up of three distinct bacterial floras: the oral microbiota, the auricular microbiota, and the nasopharyngeal microbiota.
Various diseases can result from their imbalance.

ENT microbiota

The term ENT includes three parts of the body: Ears, Nose, and Throat (which also includes the mouth).

  • The oral microbiota brings together more than 700 bacterial species, which contribute to oral health (teeth, gums, tongue, etc.) and, more generally, to overall health. A disruption in this equilibrium (dysbiosis), resulting from poor oral hygiene, a drop in immunity, or a genetic origin may lead to local infections (cavities, periodontitis, etc.) that are likely to migrate or cause more serious diseases, such as cardiovascular diseases. Hygiene and dental care remain the most effective method of prevention.
  • In the ear canal, the composition of the auricular microbiota is closely related to that of the skin. Recent work has shown the harmless presence of Alloiococcus otitis and Corynebacterium otitidis, two bacterial species that until now have only been associated with middle ear infections. This discovery suggests that the ear canal serves as an infectious reservoir for the middle ear.
  • Although close to the oral microbiota, the nasopharyngeal microbiota, which covers the nasal airways and the pharynx, is composed of very different germs.

Analyzing the realm of ENT and its microbiota may enable early diagnosis for various diseases that appear because of (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232.   ) and may also contribute to the development of personalized medicine based on probiotics.

International Microbiota Observatory

Discover the 2023 results
The Biocodex Microbiota Institute is dedicated to education about human Microbiota for General Public and Healthcare Professionals, it doesn't give any medical advice.
We recommend you to consult a healthcare professional to answer your questions and demands.
Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Microbiota